Short bowel syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
===Nutritional therapy=== | ===Nutritional therapy=== | ||
*Nutritional therapy is essential for short bowel syndrome and to restore the intestinal adaptation. It could be provided through oral, enteral and parenteral routes. | *Nutritional therapy is essential for short bowel syndrome and to restore the intestinal adaptation. It could be provided through oral, enteral and parenteral routes. | ||
** ''' | ** 1 '''Fluid''' | ||
*** Preferred regimen (1): [[drug name]] 100 mg PO q12h for 10-21 days '''(Contraindications/specific instructions)''' | *** 1.1 Acute phase | ||
*** Preferred regimen ( | **** Preferred regimen (1): [[drug name]] 100 mg PO q12h for 10-21 days '''(Contraindications/specific instructions)''' | ||
**** Preferred regimen (1): [[drug name]] 100 mg PO q12h for 10-21 days '''(Contraindications/specific instructions)''' | |||
*** | *** 1.2 Maintenance phase | ||
*** | **** Preferred regimen (1): [[drug name]] 100 mg PO q12h for 10-21 days '''(Contraindications/specific instructions)''' | ||
*** Alternative regimen ( | **** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days | ||
** | ** 2 '''Parenteral infusion''' | ||
*** | *** 2.1 Acute phase | ||
**** 2.1.1 Diet | |||
***** Preferred regimen (1): [[drug name]] 50 mg/kg PO per day q8h (maximum, 500 mg per dose) | ***** Preferred regimen (1): [[drug name]] 50 mg/kg PO per day q8h (maximum, 500 mg per dose) | ||
***** Preferred regimen (2): [[drug name]] 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose) | ***** Preferred regimen (2): [[drug name]] 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose) | ||
***** Alternative regimen (1): [[drug name]]10 mg/kg PO q6h (maximum, 500 mg per day) | ***** Alternative regimen (1): [[drug name]]10 mg/kg PO q6h (maximum, 500 mg per day) | ||
***** Alternative regimen (2): [[drug name]] 7.5 mg/kg PO q12h (maximum, 500 mg per dose) | ***** Alternative regimen (2): [[drug name]] 7.5 mg/kg PO q12h (maximum, 500 mg per dose) | ||
**** | **** 2.1.2 Electrolytes | ||
**** | **** | ||
***2.2 Maintenance phase | |||
**** Preferred regimen (1): [[drug name]] 4 mg/kg/day PO q12h(maximum, 100 mg per dose) | |||
**** Alternative regimen (1): [[drug name]] 10 mg/kg PO q6h (maximum, 500 mg per day) | |||
**** Alternative regimen (2): [[drug name]] 7.5 mg/kg PO q12h (maximum, 500 mg per dose) | |||
** | **** Alternative regimen (3): [[drug name]] 12.5 mg/kg PO q6h (maximum, 500 mg per dose) | ||
** 3 '''Enteral nutrition''' | |||
*** 1.2.1 '''Adult''' | *** 1.2.1 '''Adult''' | ||
**** Preferred regimen (1): [[drug name]] 500 mg PO q8h | **** Preferred regimen (1): [[drug name]] 500 mg PO q8h | ||
*** 1.2.2 '''Pediatric''' | *** 1.2.2 '''Pediatric''' | ||
**** Preferred regimen (1): [[drug name]] 50 mg/kg/day PO q8h (maximum, 500 mg per dose) | **** Preferred regimen (1): [[drug name]] 50 mg/kg/day PO q8h (maximum, 500 mg per dose) | ||
** 4 '''Supplement''' | |||
*** 4.1 Vitamins | |||
** | *** 4.2 Minerals | ||
* | *** 4.3 Exogenous enzyme replacement | ||
** | **** 4.3.1 Pancreatic enzyme | ||
**** 4.3.2 Lactase | |||
*** 4.4 Bile acid sequestrants | |||
*** | |||
*** | |||
**** | |||
** | |||
** | |||
*** | |||
===Pharmacotherapy=== | ===Pharmacotherapy=== |
Revision as of 22:48, 1 December 2017
Short bowel syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Short bowel syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Short bowel syndrome medical therapy |
Risk calculators and risk factors for Short bowel syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
- Management of short bowel syndrome is complicated and requires close collaboration of all medical team members including the physician, nutritionist, and nurse with the patient and their families.
- Management of short bowel syndrome consists of medical therapy and surgical interventions.
- Medical therapy consists of nutritional therapy and pharmacotherapy.
- Lifelong follow-up is usually needed.
Nutritional therapy
- Nutritional therapy is essential for short bowel syndrome and to restore the intestinal adaptation. It could be provided through oral, enteral and parenteral routes.
- 1 Fluid
- 1.1 Acute phase
- 1.2 Maintenance phase
- 2 Parenteral infusion
- 2.1 Acute phase
- 2.1.1 Diet
- Preferred regimen (1): drug name 50 mg/kg PO per day q8h (maximum, 500 mg per dose)
- Preferred regimen (2): drug name 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose)
- Alternative regimen (1): drug name10 mg/kg PO q6h (maximum, 500 mg per day)
- Alternative regimen (2): drug name 7.5 mg/kg PO q12h (maximum, 500 mg per dose)
- 2.1.2 Electrolytes
- 2.1.1 Diet
- 2.2 Maintenance phase
- Preferred regimen (1): drug name 4 mg/kg/day PO q12h(maximum, 100 mg per dose)
- Alternative regimen (1): drug name 10 mg/kg PO q6h (maximum, 500 mg per day)
- Alternative regimen (2): drug name 7.5 mg/kg PO q12h (maximum, 500 mg per dose)
- Alternative regimen (3): drug name 12.5 mg/kg PO q6h (maximum, 500 mg per dose)
- 2.1 Acute phase
- 3 Enteral nutrition
- 4 Supplement
- 4.1 Vitamins
- 4.2 Minerals
- 4.3 Exogenous enzyme replacement
- 4.3.1 Pancreatic enzyme
- 4.3.2 Lactase
- 4.4 Bile acid sequestrants
- 1 Fluid
Pharmacotherapy
Symptoms of short bowel syndrome are usually addressed by prescription medicine. These include:
- Anti-diarrheal medicine (e.g. loperamide, codeine)
- Vitamin and mineral supplements
- H2 blocker and proton pump inhibitors to reduce stomach acid
- Lactase supplement (to improve the bloating and diarrhoea associated with lactose intolerance)
- Parenteral nutrition (PN or TPN - nutrition administered via intravenous line).
- Nutrition administered via gastronomy tube